Pharma/biotech companies are increasingly looking to access large-scale data sets to fill gaps in their computational biology capabilities. Be prepared for the investment.
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- Enhancing Gene And Cell Therapies With Circular RNA-Based Gene Expression
- FDA Explains How To Respond To Form 483 Observations In New Draft Guidance
- Organizing Digital Systems Around Novel Modalities
- Achieving Annex 1 Compliance In Sterile Manufacturing, Part 1: Common Compliance Failures
- Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains
- PUPSIT In Cell & Gene Therapy: Risk Reduction Or Operational Complexity?
- Is Your AI Model Trustworthy And Credible In GMP Processes?
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![I02_michigan injmolding floor-REVISED-a (3)]( "Implementing Medium And High-Volume Drug Handling And Packaging Programs")
Implementing Medium And High-Volume Drug Handling And Packaging ProgramsSimplify the complexity of combination product development by partnering for integrated support across device design, industrialization, manufacturing, and final product assembly.
-
![GettyImages-1759287088 patient nurse consultation]( "Guiding GLP-1 Participants Through The Challenge Of Retention")
Guiding GLP-1 Participants Through The Challenge Of RetentionLearn how remote lifestyle coaching can combat high dropout rates in metabolic research by offering the support participants need to maintain adherence and ensure data integrity.
-
![GettyImages-1793747580-DNA-double-helix-AI]( "Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer")
Digital Biomanufacturing, Now: From Digital Dreamer To Digital DoerDiscover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.
-
![Corning - hyperstack]( "Expansion Of Human Bone Marrow-Derived MSCs")
Expansion Of Human Bone Marrow-Derived MSCsAchieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.
-
![GettyImages-576919878-analytics-computer-testing-research-data]( "Advancing An Integrated Biopharma Workflow Strategy")
Advancing An Integrated Biopharma Workflow StrategyGlobal research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.
-
![GettyImages-1288978528 Scientist Using Microscope In Lab]( "The Art Of Phosphitylation")
The Art Of PhosphitylationPhosphorylation is key for bioactives, with phosphoramidites favored for high selectivity. Discover how choosing specific protecting groups and new technologies fine-tunes the synthesis process.
-
![genetic research, biotechnology, molecular biology, innovation, healthcare solutions-GettyImages-2234236209]( "Automated NGS Solutions Advance Rare Disease Research")
Automated NGS Solutions Advance Rare Disease ResearchSee how a unified NGS workflow is helping a major pediatric genetics lab boost efficiency, manage growing sample volumes, and accelerate insights into rare diseases through streamlined automation.
-
![GettyImages-1413755087-business-man-computer-data-workflow-automation]( "Accelerating Clinical Data Review With Traceable Workflows")
Accelerating Clinical Data Review With Traceable WorkflowsClinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
![GettyImages-614242432-petri-dish-micro-organisms-bacteria]( "Prevent The Risk Of Cross-Contamination With Microbial Colony Pickers")
Prevent The Risk Of Cross-Contamination With Microbial Colony PickersExplore a microbial colony picker that streamlines lab workflows to ensure rapid and accurate genetic library screening. Key features include UV sanitization, pin washing, and halogen drying, which meets GMP standards.
-
![GettyImages-2187764040-cell-culture-testing-manufacturing-in-lab]( "Building A Scalable Global T Cell Manufacturing Platform")
Building A Scalable Global T Cell Manufacturing PlatformAchieve scalable T cell manufacturing with automation, standardized workflows, and integrated quality control to enable high-yield production, flexible scheduling, and seamless tech transfer.
NEWSLETTER ARCHIVE
- 07.06.26 -- In An Era Of Overcapacity, Should Companies Rent, Lease, Or Build Their Manufacturing Future?
- 07.03.26 -- Hormuz Deal Brings Cautious Relief To Pharma Packaging Supply Chains
- 07.02.26 -- New Podcast Episodes: A Midyear Look At Life Sciences, Derisking CNS Drug Development, In Vivo Gene Editing
- 07.02.26 -- Why Improving Drug Delivery Remains A Major Opportunity In Oncology
- 07.01.26 -- In Vivo Gene Editing Is Moving From Promise To Proof
- How CGT Developers Should Think About Manufacturing Models, Hybrid Strategies, And Scale
- In Vivo Gene Editing Is Moving From Promise To Proof
- Driving Gene Therapy Beyond Rare Disease Will Define The Next Era Of CGT
- CGT Manufacturing Shifts From Capacity To Strategy
- Dr. Peter Marks On Why Gene Therapy May Need A New Regulatory Playbook
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
